[Alpha-galactosidases and alpha-N-acetylgalactosaminidase. Biochemical bases of Fabry's disease]
- PMID: 6326022
[Alpha-galactosidases and alpha-N-acetylgalactosaminidase. Biochemical bases of Fabry's disease]
Abstract
The first part of this review deals with the new biochemical and genetical data concerning alpha-galactosidase and alpha-N-acetylgalactosaminidase. Molecular forms of these both enzymes can be classified into two groups following their physical, enzymatic and genetical properties: - the 3 forms of the alpha-galactosidase A group differ by the number of sialyl residues and their isoelectric point. All the forms of this group are heat-labile, hydrolyse only alpha-galactosides and proceed from the same alpha-GalA, X-linked gene. - alpha-galactosidase B is an alpha-N-acetylgalactosaminidase with broad substrate specificity, in vitro, is heat-stable and proceed from the alpha- GalB or alpha- NAGA gene of the chromosome 22. Structural and enzymatic data concerning these enzymes and their functions in the catabolism of glycosphingolipids and glycoproteins are reviewed. The second part deals with the pathophysiology of Fabry disease. The more prominent genetical and biochemical data and their diagnostic uses are reported: isozymic determination, cell cloning, quantitative determination of accumulated glycolipids. At last, were pointed the new developments of the research on Fabry disease: cultured cells as experimental model (fibroblasts, lymphoid cell lines) and therapeutic attempts.
Similar articles
-
Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.Clin Chim Acta. 1981 May 5;112(2):247-51. doi: 10.1016/0009-8981(81)90384-3. Clin Chim Acta. 1981. PMID: 6263521
-
[Biochemical study of unusual cases of Fabry disease].Vopr Med Khim. 1998 Sep-Oct;44(5):494-500. Vopr Med Khim. 1998. PMID: 9916266 Russian.
-
Molecular cloning of cDNA encoding alpha-N-acetylgalactosaminidase from Acremonium sp. and its expression in yeast.Arch Biochem Biophys. 2000 Dec 15;384(2):305-10. doi: 10.1006/abbi.2000.2114. Arch Biochem Biophys. 2000. PMID: 11368317
-
[Fabry-Anderson disease: current state of knowledge].Rev Invest Clin. 2011 May-Jun;63(3):314-21. Rev Invest Clin. 2011. PMID: 21888295 Review. Spanish.
-
[Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].J Soc Biol. 2002;196(2):183-90. J Soc Biol. 2002. PMID: 12360747 Review. French.
Cited by
-
Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.Aging (Albany NY). 2020 Nov 7;12(21):22122-22138. doi: 10.18632/aging.104075. Epub 2020 Nov 7. Aging (Albany NY). 2020. PMID: 33186124 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous